INFIQ (Infinity Pharmaceuticals) Pretax Margin %: -1,707.72% (As of Jun. 2023)

What is Infinity Pharmaceuticals Pretax Margin %?

Infinity Pharmaceuticals INFIQ -99.00% 16 Pretax Margin % is -1,707.72% as of Jun. 2023. GuruFocus rates INFIQ with a GF Score™ of 16/100.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Infinity Pharmaceuticals's Pre-Tax Income for the three months ended in Jun. 2023 was $-9.96 Mil. Infinity Pharmaceuticals's Revenue for the three months ended in Jun. 2023 was $0.58 Mil. Therefore, Infinity Pharmaceuticals's pretax margin for the quarter that ended in Jun. 2023 was -1,707.72%.

The historical rank and industry rank for Infinity Pharmaceuticals's Pretax Margin % or its related term are showing as below:

INFIQ's Pretax Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -89.895
* Ranked among companies with meaningful Pretax Margin % only.

Infinity Pharmaceuticals (OTCPK:INFIQ) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Infinity Pharmaceuticals Pretax Margin % Related Terms

Infinity Pharmaceuticals Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Infinity Pharmaceuticals's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Infinity Pharmaceuticals Pretax Margin % Chart

Infinity Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Pretax Margin %

Get a 7-Day Free Trial

-50.81

-1,545.13

-2,355.56

-2,436.06

-1,711.11

Infinity Pharmaceuticals Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Pretax Margin %	Get a 7-Day Free Trial															-1,747.23	-1,505.20	-1,699.82	-1,510.94	-1,707.72

INFIQ vs CLCS, RVLPQ, IVRN: Pretax Margin % Comparison

For the Biotechnology subindustry, Infinity Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Infinity Pharmaceuticals Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Infinity Pharmaceuticals's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Infinity Pharmaceuticals's Pretax Margin % falls into.

Save Embed

16GF Score

Infinity Pharmaceuticals Inc INFIQ

Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Infinity Pharmaceuticals Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Infinity Pharmaceuticals's Pretax Margin for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-44.369	/	2.593
	=	-1,711.11 %

Infinity Pharmaceuticals's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-9.956	/	0.583
	=	-1,707.72 %

Frequently Asked Questions Learn more about Pretax Margin % →

What does a Pretax Margin % of -1,707.72% mean?

Infinity Pharmaceuticals (INFIQ) has a Pretax Margin % of -1,707.72% as of Jun. 2023. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Infinity Pharmaceuticals and its competitors.

Is Infinity Pharmaceuticals' Pretax Margin % too high?

Infinity Pharmaceuticals' current Pretax Margin % is -1,707.72%. Overall, Infinity Pharmaceuticals has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.

How does Infinity Pharmaceuticals' Pretax Margin % compare to CLCS and RVLPQ?

Infinity Pharmaceuticals' Pretax Margin % of -1,707.72% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Pretax Margin % for a Biotechnology company?

A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Pretax Margin % mean?

A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Infinity Pharmaceuticals and its competitors. Infinity Pharmaceuticals's current Pretax Margin % is -1,707.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Infinity Pharmaceuticals stock overvalued right now?

Infinity Pharmaceuticals (INFIQ) has a current Pretax Margin % of -1,707.72%. The current Pretax Margin % is -1,707.72%. Infinity Pharmaceuticals' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Pretax Margin % calculated?

Pretax Margin % is calculated from a company's financial statements. For Infinity Pharmaceuticals (INFIQ), the current Pretax Margin % is -1,707.72% as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Infinity Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies CLCS RVLPQ IVRN RBSH TMBRQ OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX OCSE:GMAB ALNY BGNE BMRN RPRX

Address 1100 Massachusetts Avenue, Floor 4, Cambridge, MA, USA, 02138

Website https://www.infi.com

Infinity Pharmaceuticals Inc is a clinical-stage biopharmaceutical company dedicated to developing novel medicines for people with cancer. It combines proven scientific expertise with a passion for developing novel small molecule drugs that target disease pathways for potential applications in oncology. It is focused on advancing eganelisib, also known as IPI-549, an orally administered, clinical-stage, immuno-oncology product candidate that reprograms macrophages through selective inhibition of the enzyme phosphoinositide-3-kinase-gamma, or PI3K-gamma.

16GF Score

Get the complete analysis for INFIQ

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00

Price

View INFIQ Analysis

See Pretax Margin % data for all stocks →